Gut microbiome alterations in anti‐NMDA receptor encephalitis: caveats for result interpretation - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue Annals of Clinical and Translational Neurology Année : 2019

Gut microbiome alterations in anti‐NMDA receptor encephalitis: caveats for result interpretation

Résumé

Primary sclerosing cholangitis is a chronic cholestatic liver disease, whose pathogenesis remains poorly understood. Several studies have shown that PSC patients harbor an impaired gut microbiota. A recent study confirmed that PSC patients displayed a bacterial dysbiosis, characterized by an increased abundance of three different bacteria: Klebsiella pneumoniae, Proteus mirabilis and Enterococcus gallinarum. This study also provides evidence for a possible mechanism of action of these bacteria: notably the formation of pores in gut epithelium leading to an increased gut permeability and the induction of liver inflammation characterized by an increased proportion of T helper 17 (TH17) cells. For the first time, strong data demonstrate not only an association between gut microbiota and primary sclerosing cholangitis but also a possible causal link.

Dates et versions

hal-02950669 , version 1 (28-09-2020)

Identifiants

Citer

Giulia Berzero, Dimitri Psimaras, Nicolas Weiss, Harry Sokol, Agusti Alentorn. Gut microbiome alterations in anti‐NMDA receptor encephalitis: caveats for result interpretation. Annals of Clinical and Translational Neurology, 2019, 7, pp.153-154. ⟨10.1002/acn3.50969⟩. ⟨hal-02950669⟩
117 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More